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the present study was planned to validate the therapeutic 
use of this plant in treatment of inflammatory conditions.
MATERIALS AND METHODS
Chemicals
All chemicals and solvents were of analytical grade and 
obtained from Loba Chemicals Ltd, Mumbai. 1, 1-diphenyl, 
2-picryl hydrazyl (DPPH) was obtained from Sigma 
Chemicals, USA. The other chemicals used were sodium 
nitroprusside, sulphanilamide, O-phosphoric acid, napthyl 
ethylene diamine dihydrochloride, trichloroacetic acid 
INTRODUCTION 
Alocasia indica Schott. is an indigenous herb belonging 
to family Araceae. Different parts of this plant are 
traditionally used in inflammation and in diseases of 
abdomen and spleen.[1] The juice of leaves of the plant is 
used as digestive, laxative, diuretic, astringent, and for the 
treatment of rheumatic arthritis.[2] It has hepatoprotective[3] 
and antifungal properties.[4] This plant contains flavonoids, 
cynogenetic glycosides, ascorbic acid, gallic acid, mallic 
acid, oxalic acid, alocasin, amino acids, succinic acid, and 
β-lectines.[5] Since no scientific data are available to justify 
the traditional anti-inflammatory potential of the plant, 
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(TCA), glacial acetic acid, nitroblue tetrazolium (NBT), 
ethylene diamine tetra acetic acid (EDTA), riboflavin, 
and Fe-EDTA. Carrageenan was obtained from Sigma-
Aldrich, USA. Volini gel (Diclofenac sodium) was a gift 
sample from Ranbaxy Laboratories Ltd, Punjab. UV-
Visible spectrophotometer (Shimadzu 1700) was used for 
recording the spectra.
Experimental animals
Wistar albino rats weighing 175-225 g of either sex were 
obtained from Krishna Institute of Medical Sciences, Karad, 
Dist- Satara (Maharashtra) and were acclimatized for 10 days 
under standard housing conditions (24° ± 1°C; 45-55% RH 
with 12:12 h light/dark cycle). The animals had free access to 
rat food (Lipton Gold Mohr, India) and water. The animals 
were habituated to laboratory conditions for 48 h prior to 
the experimental protocol to minimize any nonspecific stress. 
The experimental protocol was approved by the Institutional 
Animal Ethics Committee by Government College of 
Pharmacy, Karad, India, and animals were maintained 
under standard conditions in the animal house approved by 
Committee for the Purpose of Control and Supervision on 
Experiments on Animals (CPCSEA). 
Plant material
Fresh leaves of A. indica Schott. (Araceae) collected from 
different places at Karad were authenticated at Botany 
Dept., Yashwantrao Chavan College of Science, Karad, 
and a voucher specimen was deposited at the Herbarium 
of institute.
Preparation of extract
The ethanolic extract of leaves of A. indica was prepared 
by soxhletion. The powdered plant material (750 g) was 
repeatedly extracted in a round bottom flask with 2250 
ml ethanol. The reflux time was 40 cycles for complete 
extraction. The extract was cooled at room temperature, 
filtered, and evaporated to dryness under reduced pressure 
in a rotary evaporator. The percentage yield was found to be 
2.79 g. The ethanolic extract of A. indica was referred as AI.
Phytochemical screening
Chemical tests were carried out on ethanolic extract of 
the plant for qualitative determination of phytochemical 
constituents.[6]
In vitro antioxidant activity
DPPH assay: To 1 ml extract of different concentrations, 
1 ml solution of DPPH (0.1 mM) was added. An equal 
amount of methanol and DPPH solution served as control. 
After 20 min of incubation in the dark, absorbance was 
measured at 517 nm.[7,8] Ascorbic acid was used as standard. 
The experiment was performed in triplicate and the 
percentage scavenging was calculated. 
Scavenging of  nitric oxide radical: Nitric oxide was generated 
from sodium nitroprusside and measured by Griss 
reaction.  [9,10] Sodium nitroprusside (5 mM) in standard 
phosphate buffer saline solution (0.025 M, pH 7.4) was 
incubated with different concentrations of (200-1000 μg/
ml) of the ethanolic extract dissolved in phosphate buffer 
saline (0.025 M, pH 7.4) and the tubes were incubated at 25 
˚C for 5 h. Control experiments without test compounds 
but with equivalent amount of buffer were conducted 
in identical manner. After 5 h, 0.5 ml of solution was 
removed and diluted with 0.5 ml of Griss reagent (2 g of 
1% sulphanilamide, 5 ml of 2% O-phosphoric acid, and 2 
g of 0.1% napthyl ethylene diamine dihydrochloride). The 
absorbance of chromophore formed during diazotization 
of nitrite with sulphanilamide and its subsequent coupling 
with napthyl ethylene diamine was read at 546 nm. Ascorbic 
acid was used as standard. The experiment was performed 
in triplicate.
Hydroxyl radical scavenging activity: Extracts of different 
concentrations (200-1000 μg/ml) were taken in different 
test tubes and evaporated on water bath. To these, 1 ml of 
Fe-EDTA, 0.5 ml of EDTA, and 1 ml DMSO were added 
and the reaction was initiated by adding 0.5 ml ascorbic acid 
to each of the test tubes. Test tubes were capped tightly and 
heated in water bath at 80-90 ˚C for 15 m. Then the reaction 
was terminated by addition of 1 ml of ice-cold TCA 
(17.5%, w/v) to all the test tubes and kept aside for 5 min. 
The formaldehyde formed was determined by adding 3 ml 
Nash reagent (75 g ammonium acetate, 3ml glacial acetic 
acid, 2 ml acetyl acetone was mixed and raised to 1 l with 
distilled water). This reaction mixture was kept aside for 
15 min for color development.[11] Intensity of yellow color 
formed was measured spectrophotometrically at 412 nm 
against reagent blank. Ascorbic acid was used as standard. 
Percentage scavenging was calculated by comparison of the 
result of the samples, standard, with that of the blank.[12]
Scavenging of  superoxide radical by riboflavin--NBT system: The 
assay was based on the capacity of the sample to inhibit 
blue formazon formation by scavenging the superoxide 
radicals generated in the riboflavin--NBT system. The 
reaction mixture contains 50 mM phosphate buffer pH 
7.6, 20 g riboflavin, 12 mM NBT. Reaction was started by 
illuminating the test samples of the extract (200-1000 μg/
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ml). The absorbance was measured at 590 nm. Ascorbic 
acid was used as positive control.[13,14] 
The percentage scavenging of each extract in different 
concentrations for different in vitro models are calculated 
by following formula:  
% Scavenging =   
Absorbance of standard - absorbance 
of extract × 100
Absorbance of standard
IC50 was calculated by using formulae:
b = Σ x. y / Σx2 
a = y – b x 
IC50 = a + b (50)
Where, b = regression coefficient of x on y; a = intercept 
of the line; x = concentration; and y = % scavenging; x 
= mean of the concentration; y = mean of % scavenging.
Antinociceptive activity
Writhing test: Writhing was induced in rat (n = 6) by 
intraperitoneal injection (10 ml/kg) of 0.6% acetic acid. 
The number of writhings was counted over a 20 min 
period as previously reported.[15,16] Animals were treated 
through oral route 30 min before injection of acetic 
acid with ethanolic extract of AI (200 and 400 mg/kg) 
or acetylsalicilic acid (200 mg/kg). The control group 
received only vehicle (3 ml/kg) of 1% suspension of 
Tween-80.
Tail immersion test: Six rats were administered orally with 
vehicle (3 ml/kg), pentazocine (30 mg/kg), and ethanolic 
extract of AI (200 and 400 mg/kg). The distal part of the 
tails of the animals was immersed in hot water maintained 
at 55.0 ± 1.0 °C. The time taken to withdraw the tail 
was noted as reaction time.[17] A cut-off time of 10 s 
was maintained at 55 °C to prevent tissue damage. The 
reaction time was measured at 0, 15, 30, 45, and 60 min 
after treatment, respectively.
Hot plate test: Rats were placed on an aluminum hot plate 
kept at 55 ± 0.5 °C for a maximum time of 30 s.[18] Reaction 
time was recorded when the animals licked their fore- and 
hind paws and jumped; at before (0) and 15, 30, 45, and 
60 min after intraperitoneal administration of 200 and 
400 mg/kg of ethanolic extract of AI to different groups 
of six animals each. Morphine 10 mg/kg was used as the 
reference drugs.
Anti-inflammatory activity 
Preparation of  gels: The gels of AI were prepared with 
carbopol-940 and PEG by cold method.[19] Different gels 
of AI (5%, 10%, and 20%) were formulated [Table 1]. 
The weighed amount of carbopol was placed in a beaker, 
and sufficient amount of water was added to it and kept 
in oven at 100 °C for 20 min to obtain a homogenous 
viscous mixture and cooled to room temperature with 
continuous stirring. Triethanolamine was added drop-wise 
with constant stirring. After formation of gel, weighed 
amount of AI was mixed in it.
Carrageenan-induced paw edema assay: The animals (n = 6) were 
divided into five groups. 0.5 g of AI gels (5%, 10% and 
20%) and marketed formulation of diclofenac sodium (2%) 
were applied to the planter surface of the left hind paw by 
gently rubbing 50 times with the index finger.[20] The gel 
base without drug was applied in control group of rats by 
the same mode of application. After 2 h, the dose 0.1 ml 
of 1% carrageenan suspension (in sterile normal saline) was 
injected subplantarly into treated and control groups of rats. 
The paw volume was measured plethysmometrically (Ugo 
Basile, Italy) at 0 and 3 h after the carrageenan injection. The 
difference between the two readings was taken as the volume 
of edema, and the percentage anti-inflammatory activity was 
calculated using following equation: 
Percentage anti-inflammatory activity = (V − Vi/Vi) 
×100, where V is the paw volume 3 h after the carrageenan 
injection and Vi is the initial paw volume.
Formalin-induced paw edema assay: The same procedure as 
mentioned above in carrageenan-induced paw edema assay 
was followed except that acute inflammation was produced 
by administration of 20 μl formalin (2.5% in distilled water) 
into the subplanter area of right hind paw of rat.[21]
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Table 1: Formulation of gels of ethanolic extract of 
Alocasia indica
Ingredients (g) Formulations (15 g)
5% 10% 20%
Ethanolic extract of Alocasia indica 0.75 1.50 3.00
carbopol-940 0.15 0.15 0.15
*PEG-4000 0.75 0.75 0.75
PEG-200 0.75 0.75 0.75
Ethanol  3.00 3.00 3.00
Triethanolamine 0.40 0.40 0.40
Methyl paraben 0.05 0.05 0.05
Propyl paraben 0.02 0.02 0.02
Distilled water 9.20 8.40 7.70
*PEG: Polyethylene glycol.140   J Young Pharm Vol 2 / No 2
Arachidonic acid-induced ear edema assay: The animals (n = 6) 
were divided into five group. Samples were given 1 h prior 
to application of arachidonic acid.[22] One hour after topical 
application of AI gels (0.5 g) and marketed formulation of 
diclofenac sodium (2%), 2% arachidonic acid dissolved in 
acetone (0.02 ml/ear) was applied to anterior and posterior 
surfaces of right ear of rat. The gel base without drug was 
applied in the control group of rats by the same mode of 
application. The ear thicknesses were measured using a dial 
thickness gauge before and at 1 and 3 h after arachidonic 
acid treatment, and the differences in the thickness were 
calculated. The degree of ear swelling was expressed as an 
increase in ear thickness in mm.
Xylene-induced ear edema assay: The same procedure as 
mentioned above in arachidonic acid-induced ear edema 
assay was followed except that acute inflammation was 
produced by applying xylene to anterior and posterior 
surfaces of right ear of rat.[23]
Statistical analysis
The statistical significance was assessed using one way 
of variance (ANOVA) followed by Bonferrini’s multiple 
comparison tests. The values are expressed as mean ± SE 
and P <0.05 was considered significant. 
RESULTS
Preliminary phytochemical investigation 
The preliminary phytochemical investigation of the 
ethanolic extract of A. indica showed that it contains 
flavonoids, cynogenetic glycosides, citric acid, ascorbic 
acid, and polyphenolic compounds. 
Antioxidant activity
Five concentrations ranging from 200 to 1000 µg/ml of 
the ethanolic extract of A. indica were tested for their 
antioxidant potential using different in vitro models. It 
was observed that free radicals were scavenged by test 
compounds at different concentrations. The maximum 
inhibitory concentration (IC50) in all models viz., DPPH, 
nitric oxide radical, superoxide, hydroxyl radical scavenging 
activity, were found to be 7.30, 10.97, 9.8, and 7.86 μg/
ml, respectively. The antioxidant model and percentage 
scavenging of each concentration of extract and standard 
are shown in Table 2.
Antinociceptive activity
Oral administration of the ethanolic extract of AI (200 and 
400 mg/kg) significantly (P < 0.05) reduced the number of 
writhings induced by acetic acid in rat [Table 3]. The activity 
was comparable to that of acetylsalicilic acid (200 mg/
kg, p.o.) used as a reference drug. Moreover, the extract 
induced protection in rat in tail immersion test [Table 4] 
that is comparable with the standard drug pentazocine 
(30 mg/kg, p.o.). The results of hot plate test presented 
in Table 5 showed that the i.p. administration of ethanolic 
extract of AI at the doses of 200–400 mg/kg significantly 
raised the pain threshold at observation time of 45 min in 
comparison with control (P < 0.001).
Stability of gels
Formulations exhibited desirable property and physical 
stability. AI was chemically stable in these formulations 
during 12-month storage at 4, 25, and 48 °C.
Anti-inflammatory activity 
Gels containing AI and marketed formulation of 
diclofenac sodium produced dose-dependent inhibition 
of carrageenan and formalin-induced paw edema as 
compared to the control (P < 0.05) [Table 6]. In xylene-
induced mouse ear edema assay gels containing AI and 
marketed formulation of diclofenac sodium significantly 
inhibited arachidonic acid and xylene-induced ear edema 
in dose  dependent as compared to the control (P < 0.05) 
[Table 7].
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Table 2: Antioxidant potential of ethanolic extract of A. indica
Different antioxidant models % Scavenging at different concentration (μg/ml) [values are mean of three replicates]
AA* (μg/ml) Test extract: A. indica.
200 50 100 200 400 800 1000 IC50
DPPH** 88.75 40.24 44.62 53.25 61.39 63.46 73.48 7.30
Nitric oxide 74.54 34.74 53.44 63.48 71.59 73.51 84.09 10.97
Hydroxyl radical 62.35 43.24 55.37 66.15 57.23 59.28 67.96 9.8
Superoxide radical 88.25 47.26 52.18 65.71 68.12 52.84 77.17 7.86
*Ascorbic acid; **1,1-diphenyl, 2-picryl hydrazyl.J Young Pharm Vol 2 / No 2  141
Table 3: Effect of the ethanolic extract of leaves of 
Alocasia indica (AI) on acetic acid-induced writhing in 
rat
Material Dose  
(mg/kg)
No. of writhings Inhibition 
(%)
Control -- 45.7 ± 4.2
Acetylsalicylic acid 200 11.8 ± 2.4* 74.17
AI 200 21.5 ± 1.9** 52.95
400 14.5 ± 1.8* 68.27
*P < 0.05, **P < 0.01 vs. control, [Values are mean ± SE from six animals in each 
group.]
Table 4: Effect of the ethanolic extract of leaves of Alocasia indica (AI) on tail immersion method in rat
Treatment  Dose (mg/kg) Average tail withdrawing time (s)
0 min 15 min 30 min 45 min 60 min
Control -- 4.20 ± 0.11 4.65 ± 0.18 4.77 ± 0.17 4.77 ± 0.15 4.80 ± 0.18
Pentazocine 30 4.16 ± 0.20* 5.39 ± 0.21* 7.37 ± 0.45* 7.53 ± 0.29* 8.18 ± 0.27*
AI 200 4.25 ± 0.21* 4.53 ± 0.12** 5.27 ± 0.13* 5.35 ± 0.18** 5.27 ± 0.11**
400 4.62 ± 0.16* 4.17 ± 0.28* 6.92 ± 0.48** 7.05 ± 0.28* 8.48 ± 0.27**
*P < 0.05, **P < 0.01 vs. control, [Values are mean ± SE from six animals in each group.]
Table 5: Effect of the ethanolic extract of leaves of A. indica (AI) on rat submitted to the hot plate test
Treatment Dose (mg/kg) Time 0 (min) Time 15 (min) Time 30 (min) Time 45 (min) Time 60 (min)
Control – 6.25 ± 0.35 6.32 ± 0.24 6.38 ± 0.31 7.15 ± 0.38 6.16 ± 0.54
Morphine 10 6.41 ± 0.35* 12.65 ± 0.48* 14.20 ± 0.36** 14.99 ± 0.81** 14.45 ± 0.56**
AI 200 5.76 ± 0.24** 10.16 ± 0.50* 13.21 ± 0.41* 14.17 ± 0.25** 12.16 ± 0.50*
400 6.40 ± 0.48** 12.10 ± 0.31** 13.56 ± 0.73* 14.86 ± 0.72** 12.67 ± 0.78**
*P < 0.05, **P < 0.01 vs. control, [Values are mean ± SE from six animals in each group.]
Table 6: Effects of the Alocasia indica gels (AI: 5%, 10%, 20%) and marketed formulation of diclofenac sodium (DS: 
2%) on carrageenan-induced rat paw edema and formalin-induced paw edema
Group Carrageenan-induced rat paw edema Formalin-induced rat paw edema
Increase in paw volume 
(mean ± SEM) in ml
% Inhibition of paw edema Increase in paw volume 
(mean ± SEM) in ml
% inhibition of paw edema
Control  0.67 ± 0.13 - 0.58 ± 0.12 -
AI (5%) 0.37 ± 0.07* 59.5 0.36 ± 0.05* 52.3
AI (10%) 0.32 ± 0.05* 66.6 0.31 ± 0.06* 58.1
AI (20%) 0.26 ± 0.03* 72.2 0.25 ± 0.02* 62.4
DS (2%) 0.20 ± 0.02* 83.1 0.19 ± 0.01** 73.7
*P < 0.05, **P < 0.01 vs. control. [Values are mean ± SE from six animals in each group.]
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DISCUSSION
Recent studies suggest that the inflammatory tissue 
damages are due to the liberation of reactive oxygen 
species from phagocytes invading the inflammation   
sites.[24-26] In addition to this, nitric oxide is also implicated in 
inflammation, cancer, and other pathological conditions.[27] 
Interactions between superoxide and nitric oxide regulate 
the vascular tone or inflammation.[28] The significant in 
vitro antioxidant activity of AI was in a concentration-
dependent manner. 
The ethanolic extract of AI at the doses of 200–400 mg/kg 
protected rat against both chemical- and thermal-induced 
noxious stimuli, which were evidenced from the acetic acid-
induced writhing, tail immersion, and hot plate tests. Acetic 
acid induces writhing syndromes[15,16] and causes analgesia 
by releasing of endogenous substances, which then 
excite the pain nerve endings; the abdominal constriction 
is related to the sensitization of nociceptive receptors 
to prostaglandins.  [29] Hot plate test was also assayed to 
characterize the analgesic activity of extract. It is possible 
that ethanol extract of AI extract exerts an analgesic effect 
probably by inhibiting the synthesis of prostaglandins. 
Variation in order of activity for ethanol extract of AI 
fractions in acetic acid-induced writhing, tail immersion, 
and hot plate tests indicated that the different constituents 
present in different fractions may be responsible for central 
and peripheral analgesia.
Carrageenan-induced edema is a biphasic response in 
which the involvement of the cyclo-oxygenase products 
of arachidonic acid metabolism and the production of 
reactive oxygen species are well established.[30] The first 142   J Young Pharm Vol 2 / No 2
phase is mediated through the release of histamine, 
serotonin, and kinins, whereas the second phase is related 
to the release of prostaglandin oxygen-derived free 
radicals and production of inducible cyclo-oxygenase 
which peak at 3 h.[31] The AI extract produced dose-
dependent and significant inhibition of carrageenan-
induced paw edema comparable in magnitude with the 
inhibitory action of diclofenac. The formalin-induced 
paw edema assay defines distinctive biphasic nociceptive 
response termed neurogenic and inflammatory phases.[32] 
The ability of AI to have effect on both phases shows 
that it contains active anti-inflammatory principle acting 
both centrally and peripherally.
Another model of inflammation used is the ear edema 
induced by arachidonic acid and xylene, which serves to 
identify the mediators of inflammation of the lipoxygenase 
pathway.[33,34] Topical application of the gels of AI extract 
at the concentrations of 5%, 10%, and 20% inhibited 
the ear edema induced by arachidonic acid and xylene in 
dose-dependent manner similar to diclofenac. The results 
show that the AI acts on both the cyclo-oxygenase and 
lipoxygenase pathways. 
Preliminary phytochemical screening showed that ethanolic 
extract of the leaves of A. indica contains flavonoid 
compounds. Flavonoids have been shown to possess 
various biological properties related to antioxidant, 
antinociceptive, and anti-inflammatory mechanisms by 
targeting reactive oxygen species and prostaglandins which 
are involved in the late phase of acute inflammation and 
pain perception.[35-37] It can be concluded that ethanolic 
extract of A. indica possess antioxidant, antinociceptive, and 
anti-inflammatory activities may be due to the presence of 
flavonoids and other polyphenolic moieties present in it, 
which seems to support the use of this plant in traditional 
medicine. Finally, the precise mechanism(s) and site(s) of 
this activity and the active constituent(s) involved are still 
to be determined in addition to toxicological studies.
Table 7: Effects of the Alocasia indica gels (AI: 5%, 10%, 20%) and marketed formulation of diclofenac sodium (DS: 
2%) on arachidonic acid-induced ear edema and xylene-induced ear edema
Group Arachidonic acid-induced ear edema Xylene-induced ear edema
Increase in paw volume 
(mean ± SEM) in ml
% Inhibition of paw edema Increase in paw volume 
(mean ± SEM) in ml
% Inhibition of paw 
edema
Control  0.27 ± 0.08 - 0.24 ± 0.05 -
AI (5%) 0.19 ± 0.06* 42.1 0.17 ± 0.06* 41.2
AI (10%) 0.15 ± 0.02* 45.3 0.14 ± 0.03* 44.4
AI (20%) 0.13 ± 0.03* 52.2 0.12 ± 0.03* 53.6
DS (2%) 0.09 ± 0.01** 63.5 0.08 ± 0.01** 61.1
*P < 0.05, **P < 0.01 vs. control., [Values are mean ± SE from six animals in each group.]
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